You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human leukocyte antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platelet Refractoriness, Hematologic Malignancy Trial in Charlottesville (isatuximab 10 mg/kg)

Recruiting
  • Platelet Refractoriness
  • Hematologic Malignancy
  • isatuximab 10 mg/kg
  • Charlottesville, Virginia
    University of Virginia
Jan 27, 2023

Human Leukocyte Antigen Typing and Tumor Antigen Expression

Recruiting
  • Refractory Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Feb 14, 2022

    Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)

    Not yet recruiting
    • Chronic Kidney Disease (CKD)
    • New York, New York
      New York University Langone Health - Transplant Institute
    Jul 11, 2022

    Monocyte Expression of Human Leukocyte Antigen - DR Isotype

    Recruiting
    • Critical Care
    • Blood sampling
    • Lyon, France
      Service de reanimation chirurgicale
    Oct 27, 2022

    Ependymoma Trial in Pittsburgh (biological, drug, other)

    Recruiting
    • Ependymoma
    • HLA-A2 restricted synthetic tumor antigen
    • +5 more
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of UPMC
    Oct 23, 2022

    Corticosteroids Induced Immunosuppression Using Monocyte Human

    Not yet recruiting
    • Immunosuppression
    • mHLA-DR
    • (no location specified)
    Jan 17, 2022

    Nanoparticle for DSA Removal

    Recruiting
    • Kidney Failure
    • Presence of Donor Specific Antibodies
      • Zurich, ZH, Switzerland
        University Hospital Zurich, Division of Anaesthesiology
      Mar 11, 2022

      Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

      Not yet recruiting
      • Kidney Transplant Rejection
      • MDR-102
      • Immunosuppressive Agents
      • (no location specified)
      Apr 4, 2022

      Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

      Suspended
      • Hematologic Malignancies
      • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
      • La Jolla, California
        UCSD Medical Center
      Jul 20, 2022

      End Stage Renal Disease Trial in Los Angeles (Tacrolimus Extended-Release Oral Capsule)

      Completed
      Has Results
      • End Stage Renal Disease
      • Tacrolimus Extended-Release Oral Capsule
      • Los Angeles, California
        Cedars Sinai Medical Center
      Jan 7, 2022

      Postoperative Infectious Complications in Colorectal Cancer

      Completed
      • Colorectal Cancer
        • Moscow, Russian Federation
          State Scientific Centre of Coloproctology
        Sep 21, 2021

        NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +5 more
        • Autologous, engineered T Cells targeting TP53 R175H
        • Duarte, California
          City of Hope
        May 17, 2023

        Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

        Recruiting
        • Living Donor Kidney Transplantation
        • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
        • Palo Alto, California
        • +1 more
        May 6, 2022

        Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

        Active, not recruiting
        • Hematologic Malignancy
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Jan 21, 2022

        Immunoglobulins, Plasmapheresis and Rituximab in Lung

        Recruiting
        • Lung Transplantation
        • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
        • blood samples
        • Hannover, Germany
          Hannover Medical School, Department of Cardiothoracic, Transplan
        Aug 30, 2021

        Human Leukocyte Antigen Class II Alleles and Haplotypes

        Recruiting
        • Pemphigus
        • +3 more
        • A single blood sample for HLA typing
        • Moscow, Russian Federation
          Sechenov University
        Mar 10, 2022

        Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)

        Completed
        Has Results
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndrome
        • Durham, North Carolina
          Duke University Medical Center
        Dec 1, 2020

        Breast Cancer Trial in Tampa, Boston, New York (PVX-410, Durvalumab, Hiltonol)

        Active, not recruiting
        • Breast Cancer
        • PVX-410
        • +2 more
        • Tampa, Florida
        • +4 more
        May 7, 2021

        Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

        Terminated
        • Head and Neck Cancer
        • +7 more
        • Tumor Profiling
        • Scottsdale, Arizona
        • +2 more
        Dec 2, 2022

        Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

        Recruiting
        • Influenza A
        • Pandemic Influenza
        • H7HLAII
        • Oslo, Norway
          Oslo University Hospital
        Sep 20, 2023

        Inflammatory and Anti-Inflammatory Gene Expressions in Liver

        Active, not recruiting
        • Liver Transplant; Complications
        • +3 more
        • Molecular Immunology , gene expressions
        • Malatya, Turkey
          İnönü University
        May 2, 2023

        Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

        Recruiting
        • Sickle Cell Disease
        • Bone Marrow Transplant (BMT)
        • +7 more
        • Atlanta, Georgia
          Children's Healthcare of Atlanta
        Sep 13, 2022

        Multiple Myeloma Trial in Houston (Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A))

        Not yet recruiting
        • Multiple Myeloma
        • Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        Jan 13, 2023

        Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

        Not yet recruiting
        • Small Cell Lung Cancer Extensive Stage
        • Large Cell Neuroendocrine Carcinoma of the Lung
        • LB2102
        • (no location specified)
        Jan 10, 2023

        Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

        Not yet recruiting
        • Influenza, Human
        • ARCT-2138
        • +2 more
        • Brisbane, Queensland, Australia
          Nucleus Network Brisbane Clinic
        Nov 8, 2023